InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Thursday, 11/12/2020 1:49:18 PM

Thursday, November 12, 2020 1:49:18 PM

Post# of 16706
Sure happy this management is so frugal with our investments and PP monies. 140M OS is miniscule compared to some competition to get this Drug through initial Trials.
They have also waited to present data until it would Not affect patients or further data. In Smoki's posted Video, CM says the Trial will be wrapped up by then.
Gathering Data from around the World, where some Trial Sites are located, may present some challenges and of course some sites will complete prior to others. Of course #2, this wide variety will make the data all that more accepted, IMO.
The next gathered data will follow in a couple weeks, possibly. BigPharma is shooting blanks so far compared to the NEEDS and $$$ thrown at this disease.
The three Arms of this Trial are open label but actual presentable Data will need to be documented in the proper formats for reviews after release of 'raw' data from the Trial Sites.

@ 140M OS, a Biggie can partner here cheap for quicker production and distribution of Ifenprodil ($1B+) or maybe buyout the 'Rights' for a couple $B and we will All be Very Happy.
Yes, I suggest we take BigP Shares if that's the offer. Yes, I suggest Royalties may also be a good path for AGN shareholders with up front Licensing fees.....

Other solutions to join the COVID fight are very expensive for patients, they may have long infusion courses and/or logistics and production issues when scaling up to the NEEDED amounts, Worldwide.

IFENPRODIL is an inexpensive, easily produced and proven safe PILL and we will soon Officially hear how well it worked. Obviously it passed Safety and Futility reviews, UNANAMOUSLY, already...